All Stories

Featured Stories

Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems

Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems

For U.S. healthcare systems, clinical and financial stability can be achieved when we look beyond treatment options for individual disease states and instead take a more holistic approach that also addresses the pathological mechanisms that extend across multiple disease states. The American Heart Association definition of the cardiovascular-kidney-metabolic syndrome (CKM syndrome), a systemic overlap of […]
READ MORE >
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression

SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression

For years, kidney care has primarily focused on managing kidney failure. Now, new data is empowering a crucial clinical focus: preserving kidney function before kidney disease advances. A recent study published in JAMA Internal Medicine provides a compelling signal for care providers: When it comes to slowing chronic kidney disease (CKD) progression for people with […]
READ MORE >
The Doctor Will See You Now: The Value of Human Connection in AI-Supported Medicine

The Doctor Will See You Now: The Value of Human Connection in AI-Supported Medicine

As artificial intelligence (AI) continues to take hold across all industries, Adam Weinstein, MD, chief medical information officer for DaVita, highlights how new technological capabilities also help make the human connection more central to healthcare. Recently, a New York Times article explored the question of whether advancements to AI in medicine could reduce the value […]
READ MORE >

This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.